nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ADRB1—dilated cardiomyopathy	0.423	0.543	CbGaD
Acebutolol—ADRB2—dilated cardiomyopathy	0.356	0.457	CbGaD
Acebutolol—ABCB1—Lisinopril—dilated cardiomyopathy	0.0655	0.532	CbGbCtD
Acebutolol—ABCB1—Spironolactone—dilated cardiomyopathy	0.0577	0.468	CbGbCtD
Acebutolol—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00297	0.0382	CcSEcCtD
Acebutolol—Atrioventricular block complete—Lisinopril—dilated cardiomyopathy	0.00266	0.0342	CcSEcCtD
Acebutolol—Lung infiltration—Lisinopril—dilated cardiomyopathy	0.00198	0.0255	CcSEcCtD
Acebutolol—Appetite absent—Lisinopril—dilated cardiomyopathy	0.00187	0.024	CcSEcCtD
Acebutolol—Lethargy—Spironolactone—dilated cardiomyopathy	0.00169	0.0217	CcSEcCtD
Acebutolol—SLC22A1—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.00153	0.14	CbGpPWpGaD
Acebutolol—Heartburn—Lisinopril—dilated cardiomyopathy	0.00135	0.0174	CcSEcCtD
Acebutolol—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00132	0.0169	CcSEcCtD
Acebutolol—Throat sore—Lisinopril—dilated cardiomyopathy	0.00129	0.0166	CcSEcCtD
Acebutolol—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.00128	0.0164	CcSEcCtD
Acebutolol—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00127	0.0164	CcSEcCtD
Acebutolol—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00119	0.0153	CcSEcCtD
Acebutolol—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00111	0.0143	CcSEcCtD
Acebutolol—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00104	0.0948	CbGpPWpGaD
Acebutolol—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00102	0.0131	CcSEcCtD
Acebutolol—Alopecia—Spironolactone—dilated cardiomyopathy	0.00101	0.013	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000953	0.0123	CcSEcCtD
Acebutolol—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000924	0.0119	CcSEcCtD
Acebutolol—Lethargy—Furosemide—dilated cardiomyopathy	0.000918	0.0118	CcSEcCtD
Acebutolol—Wheezing—Lisinopril—dilated cardiomyopathy	0.000903	0.0116	CcSEcCtD
Acebutolol—Malaise—Spironolactone—dilated cardiomyopathy	0.000898	0.0115	CcSEcCtD
Acebutolol—Discomfort—Spironolactone—dilated cardiomyopathy	0.000837	0.0108	CcSEcCtD
Acebutolol—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000832	0.0107	CcSEcCtD
Acebutolol—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000821	0.0106	CcSEcCtD
Acebutolol—Confusional state—Spironolactone—dilated cardiomyopathy	0.000819	0.0105	CcSEcCtD
Acebutolol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.000748	0.0683	CbGpPWpGaD
Acebutolol—Practolol—ADRB1—dilated cardiomyopathy	0.000728	0.0859	CrCbGaD
Acebutolol—Somnolence—Spironolactone—dilated cardiomyopathy	0.000722	0.00929	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000701	0.00902	CcSEcCtD
Acebutolol—Drowsiness—Furosemide—dilated cardiomyopathy	0.000693	0.00891	CcSEcCtD
Acebutolol—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000675	0.00868	CcSEcCtD
Acebutolol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000669	0.00861	CcSEcCtD
Acebutolol—Sweating—Furosemide—dilated cardiomyopathy	0.000664	0.00854	CcSEcCtD
Acebutolol—Metipranolol—ADRB1—dilated cardiomyopathy	0.000659	0.0777	CrCbGaD
Acebutolol—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000647	0.00832	CcSEcCtD
Acebutolol—Urticaria—Spironolactone—dilated cardiomyopathy	0.000645	0.0083	CcSEcCtD
Acebutolol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000642	0.00826	CcSEcCtD
Acebutolol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00062	0.0565	CbGpPWpGaD
Acebutolol—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000616	0.00792	CcSEcCtD
Acebutolol—Visual impairment—Furosemide—dilated cardiomyopathy	0.0006	0.00771	CcSEcCtD
Acebutolol—Tinnitus—Furosemide—dilated cardiomyopathy	0.00058	0.00746	CcSEcCtD
Acebutolol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000575	0.00739	CcSEcCtD
Acebutolol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000574	0.00738	CcSEcCtD
Acebutolol—Angiopathy—Furosemide—dilated cardiomyopathy	0.000564	0.00726	CcSEcCtD
Acebutolol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000556	0.00715	CcSEcCtD
Acebutolol—Metipranolol—ADRB2—dilated cardiomyopathy	0.000554	0.0653	CrCbGaD
Acebutolol—Dysuria—Lisinopril—dilated cardiomyopathy	0.000545	0.00701	CcSEcCtD
Acebutolol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000537	0.00691	CcSEcCtD
Acebutolol—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000537	0.00691	CcSEcCtD
Acebutolol—Flatulence—Furosemide—dilated cardiomyopathy	0.000534	0.00686	CcSEcCtD
Acebutolol—Weight increased—Lisinopril—dilated cardiomyopathy	0.000531	0.00682	CcSEcCtD
Acebutolol—Esmolol—ADRB1—dilated cardiomyopathy	0.000523	0.0617	CrCbGaD
Acebutolol—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000523	0.00672	CcSEcCtD
Acebutolol—Depression—Lisinopril—dilated cardiomyopathy	0.000518	0.00667	CcSEcCtD
Acebutolol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000517	0.00664	CcSEcCtD
Acebutolol—Rash—Spironolactone—dilated cardiomyopathy	0.000512	0.00659	CcSEcCtD
Acebutolol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000512	0.00658	CcSEcCtD
Acebutolol—Vision blurred—Furosemide—dilated cardiomyopathy	0.00051	0.00656	CcSEcCtD
Acebutolol—Headache—Spironolactone—dilated cardiomyopathy	0.000509	0.00654	CcSEcCtD
Acebutolol—Sweating—Lisinopril—dilated cardiomyopathy	0.000498	0.00641	CcSEcCtD
Acebutolol—Vertigo—Furosemide—dilated cardiomyopathy	0.000487	0.00626	CcSEcCtD
Acebutolol—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000485	0.00624	CcSEcCtD
Acebutolol—Nausea—Spironolactone—dilated cardiomyopathy	0.000483	0.0062	CcSEcCtD
Acebutolol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000475	0.00611	CcSEcCtD
Acebutolol—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000468	0.00602	CcSEcCtD
Acebutolol—Hallucination—Lisinopril—dilated cardiomyopathy	0.000464	0.00597	CcSEcCtD
Acebutolol—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000463	0.00596	CcSEcCtD
Acebutolol—Betaxolol—ADRB1—dilated cardiomyopathy	0.000461	0.0543	CrCbGaD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000458	0.00589	CcSEcCtD
Acebutolol—Atenolol—ADRB1—dilated cardiomyopathy	0.000457	0.0539	CrCbGaD
Acebutolol—Confusional state—Furosemide—dilated cardiomyopathy	0.000446	0.00573	CcSEcCtD
Acebutolol—Bisoprolol—ADRB1—dilated cardiomyopathy	0.000445	0.0525	CrCbGaD
Acebutolol—Esmolol—ADRB2—dilated cardiomyopathy	0.00044	0.0519	CrCbGaD
Acebutolol—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000435	0.0056	CcSEcCtD
Acebutolol—Shock—Furosemide—dilated cardiomyopathy	0.000435	0.00559	CcSEcCtD
Acebutolol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000433	0.00557	CcSEcCtD
Acebutolol—Flushing—Lisinopril—dilated cardiomyopathy	0.000433	0.00557	CcSEcCtD
Acebutolol—Skin disorder—Furosemide—dilated cardiomyopathy	0.000429	0.00552	CcSEcCtD
Acebutolol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000427	0.00549	CcSEcCtD
Acebutolol—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000423	0.00545	CcSEcCtD
Acebutolol—Anorexia—Furosemide—dilated cardiomyopathy	0.000421	0.00542	CcSEcCtD
Acebutolol—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000421	0.00541	CcSEcCtD
Acebutolol—Chills—Lisinopril—dilated cardiomyopathy	0.000419	0.00539	CcSEcCtD
Acebutolol—Oxprenolol—ADRB1—dilated cardiomyopathy	0.000418	0.0493	CrCbGaD
Acebutolol—Hypotension—Furosemide—dilated cardiomyopathy	0.000413	0.00531	CcSEcCtD
Acebutolol—Alopecia—Lisinopril—dilated cardiomyopathy	0.000412	0.0053	CcSEcCtD
Acebutolol—Flatulence—Lisinopril—dilated cardiomyopathy	0.0004	0.00515	CcSEcCtD
Acebutolol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000397	0.0051	CcSEcCtD
Acebutolol—Back pain—Lisinopril—dilated cardiomyopathy	0.000393	0.00505	CcSEcCtD
Acebutolol—Somnolence—Furosemide—dilated cardiomyopathy	0.000393	0.00505	CcSEcCtD
Acebutolol—Betaxolol—ADRB2—dilated cardiomyopathy	0.000387	0.0457	CrCbGaD
Acebutolol—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000384	0.00494	CcSEcCtD
Acebutolol—Atenolol—ADRB2—dilated cardiomyopathy	0.000384	0.0453	CrCbGaD
Acebutolol—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000383	0.00492	CcSEcCtD
Acebutolol—Alprenolol—ADRB1—dilated cardiomyopathy	0.000383	0.0451	CrCbGaD
Acebutolol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000382	0.00491	CcSEcCtD
Acebutolol—Fatigue—Furosemide—dilated cardiomyopathy	0.000381	0.0049	CcSEcCtD
Acebutolol—Pain—Furosemide—dilated cardiomyopathy	0.000378	0.00486	CcSEcCtD
Acebutolol—Constipation—Furosemide—dilated cardiomyopathy	0.000378	0.00486	CcSEcCtD
Acebutolol—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000377	0.00485	CcSEcCtD
Acebutolol—Bisoprolol—ADRB2—dilated cardiomyopathy	0.000374	0.0441	CrCbGaD
Acebutolol—Malaise—Lisinopril—dilated cardiomyopathy	0.000366	0.00471	CcSEcCtD
Acebutolol—Vertigo—Lisinopril—dilated cardiomyopathy	0.000365	0.00469	CcSEcCtD
Acebutolol—Syncope—Lisinopril—dilated cardiomyopathy	0.000364	0.00469	CcSEcCtD
Acebutolol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000364	0.00468	CcSEcCtD
Acebutolol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000361	0.00465	CcSEcCtD
Acebutolol—Palpitations—Lisinopril—dilated cardiomyopathy	0.000359	0.00462	CcSEcCtD
Acebutolol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000357	0.00459	CcSEcCtD
Acebutolol—Metoprolol—ADRB1—dilated cardiomyopathy	0.000356	0.042	CrCbGaD
Acebutolol—Cough—Lisinopril—dilated cardiomyopathy	0.000355	0.00456	CcSEcCtD
Acebutolol—Oxprenolol—ADRB2—dilated cardiomyopathy	0.000352	0.0415	CrCbGaD
Acebutolol—Urticaria—Furosemide—dilated cardiomyopathy	0.000351	0.00451	CcSEcCtD
Acebutolol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000349	0.00449	CcSEcCtD
Acebutolol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000349	0.00449	CcSEcCtD
Acebutolol—Chest pain—Lisinopril—dilated cardiomyopathy	0.000346	0.00445	CcSEcCtD
Acebutolol—Myalgia—Lisinopril—dilated cardiomyopathy	0.000346	0.00445	CcSEcCtD
Acebutolol—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000346	0.00445	CcSEcCtD
Acebutolol—Anxiety—Lisinopril—dilated cardiomyopathy	0.000345	0.00443	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000344	0.00442	CcSEcCtD
Acebutolol—Discomfort—Lisinopril—dilated cardiomyopathy	0.000342	0.00439	CcSEcCtD
Acebutolol—Confusional state—Lisinopril—dilated cardiomyopathy	0.000334	0.0043	CcSEcCtD
Acebutolol—Oedema—Lisinopril—dilated cardiomyopathy	0.000332	0.00426	CcSEcCtD
Acebutolol—Pindolol—ADRB1—dilated cardiomyopathy	0.000329	0.0388	CrCbGaD
Acebutolol—Shock—Lisinopril—dilated cardiomyopathy	0.000326	0.0042	CcSEcCtD
Acebutolol—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000322	0.00414	CcSEcCtD
Acebutolol—Alprenolol—ADRB2—dilated cardiomyopathy	0.000322	0.038	CrCbGaD
Acebutolol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000321	0.00412	CcSEcCtD
Acebutolol—Asthenia—Furosemide—dilated cardiomyopathy	0.000317	0.00408	CcSEcCtD
Acebutolol—Anorexia—Lisinopril—dilated cardiomyopathy	0.000316	0.00406	CcSEcCtD
Acebutolol—Pruritus—Furosemide—dilated cardiomyopathy	0.000313	0.00402	CcSEcCtD
Acebutolol—Hypotension—Lisinopril—dilated cardiomyopathy	0.00031	0.00398	CcSEcCtD
Acebutolol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000302	0.00389	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000302	0.00389	CcSEcCtD
Acebutolol—Insomnia—Lisinopril—dilated cardiomyopathy	0.0003	0.00386	CcSEcCtD
Acebutolol—Metoprolol—ADRB2—dilated cardiomyopathy	0.000299	0.0353	CrCbGaD
Acebutolol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000298	0.00383	CcSEcCtD
Acebutolol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000296	0.0038	CcSEcCtD
Acebutolol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000295	0.00379	CcSEcCtD
Acebutolol—Dizziness—Furosemide—dilated cardiomyopathy	0.000292	0.00376	CcSEcCtD
Acebutolol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000292	0.00375	CcSEcCtD
Acebutolol—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000288	0.00371	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000286	0.00368	CcSEcCtD
Acebutolol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000286	0.00368	CcSEcCtD
Acebutolol—Pain—Lisinopril—dilated cardiomyopathy	0.000284	0.00365	CcSEcCtD
Acebutolol—Constipation—Lisinopril—dilated cardiomyopathy	0.000284	0.00365	CcSEcCtD
Acebutolol—Vomiting—Furosemide—dilated cardiomyopathy	0.000281	0.00361	CcSEcCtD
Acebutolol—Rash—Furosemide—dilated cardiomyopathy	0.000279	0.00358	CcSEcCtD
Acebutolol—Dermatitis—Furosemide—dilated cardiomyopathy	0.000278	0.00358	CcSEcCtD
Acebutolol—Headache—Furosemide—dilated cardiomyopathy	0.000277	0.00356	CcSEcCtD
Acebutolol—Pindolol—ADRB2—dilated cardiomyopathy	0.000277	0.0326	CrCbGaD
Acebutolol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000273	0.00351	CcSEcCtD
Acebutolol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000271	0.00349	CcSEcCtD
Acebutolol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000265	0.0241	CbGpPWpGaD
Acebutolol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000263	0.00339	CcSEcCtD
Acebutolol—Nausea—Furosemide—dilated cardiomyopathy	0.000263	0.00338	CcSEcCtD
Acebutolol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000262	0.00337	CcSEcCtD
Acebutolol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000262	0.00337	CcSEcCtD
Acebutolol—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000251	0.0229	CbGpPWpGaD
Acebutolol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000238	0.00306	CcSEcCtD
Acebutolol—Pruritus—Lisinopril—dilated cardiomyopathy	0.000235	0.00302	CcSEcCtD
Acebutolol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000227	0.00292	CcSEcCtD
Acebutolol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000222	0.0203	CbGpPWpGaD
Acebutolol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000219	0.00282	CcSEcCtD
Acebutolol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000219	0.02	CbGpPWpGaD
Acebutolol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.000216	0.0197	CbGpPWpGaD
Acebutolol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000211	0.00271	CcSEcCtD
Acebutolol—Rash—Lisinopril—dilated cardiomyopathy	0.000209	0.00269	CcSEcCtD
Acebutolol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000209	0.00269	CcSEcCtD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000208	0.019	CbGpPWpGaD
Acebutolol—Headache—Lisinopril—dilated cardiomyopathy	0.000208	0.00267	CcSEcCtD
Acebutolol—Nausea—Lisinopril—dilated cardiomyopathy	0.000197	0.00253	CcSEcCtD
Acebutolol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000184	0.0168	CbGpPWpGaD
Acebutolol—Propranolol—ADRB1—dilated cardiomyopathy	0.00018	0.0212	CrCbGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000171	0.0156	CbGpPWpGaD
Acebutolol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.00017	0.0155	CbGpPWpGaD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000167	0.0153	CbGpPWpGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000167	0.0152	CbGpPWpGaD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000163	0.0149	CbGpPWpGaD
Acebutolol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000156	0.0142	CbGpPWpGaD
Acebutolol—Propranolol—ADRB2—dilated cardiomyopathy	0.000151	0.0178	CrCbGaD
Acebutolol—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000147	0.0134	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000138	0.0126	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000135	0.0123	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000121	0.0111	CbGpPWpGaD
Acebutolol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.000113	0.0103	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000104	0.00949	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	9.46e-05	0.00863	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	9.18e-05	0.00837	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	8.31e-05	0.00759	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	7.97e-05	0.00727	CbGpPWpGaD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	7.92e-05	0.00723	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	7.6e-05	0.00693	CbGpPWpGaD
Acebutolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	7.22e-05	0.00659	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	7.1e-05	0.00648	CbGpPWpGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	6.68e-05	0.0061	CbGpPWpGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	6.56e-05	0.00599	CbGpPWpGaD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	6.54e-05	0.00597	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	5.97e-05	0.00545	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	5.8e-05	0.00529	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	5.67e-05	0.00517	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	5.39e-05	0.00492	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	5.27e-05	0.00481	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	5.11e-05	0.00466	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	5.01e-05	0.00457	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	4.97e-05	0.00453	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	4.97e-05	0.00453	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.94e-05	0.00451	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	4.86e-05	0.00443	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	4.86e-05	0.00443	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.81e-05	0.00439	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.81e-05	0.00439	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	4.65e-05	0.00425	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	4.62e-05	0.00421	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	4.52e-05	0.00412	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	4.49e-05	0.00409	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.47e-05	0.00408	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	4.46e-05	0.00407	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	4.37e-05	0.00399	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	4.36e-05	0.00398	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	4.23e-05	0.00386	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	3.82e-05	0.00348	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	3.78e-05	0.00345	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	3.78e-05	0.00345	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	3.74e-05	0.00341	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	3.7e-05	0.00338	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	3.7e-05	0.00338	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	3.62e-05	0.00331	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	3.52e-05	0.00321	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	3.44e-05	0.00314	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	3.33e-05	0.00304	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	3.25e-05	0.00296	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	3.06e-05	0.00279	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.91e-05	0.00265	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.9e-05	0.00264	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	2.85e-05	0.0026	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.82e-05	0.00257	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.82e-05	0.00257	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	2.76e-05	0.00252	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	2.76e-05	0.00252	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.69e-05	0.00245	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	2.63e-05	0.0024	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.62e-05	0.00239	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	2.37e-05	0.00216	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.3e-05	0.0021	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.21e-05	0.00202	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.17e-05	0.00198	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.14e-05	0.00195	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.14e-05	0.00195	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.09e-05	0.00191	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.09e-05	0.00191	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	2.05e-05	0.00187	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	2e-05	0.00183	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.99e-05	0.00181	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	1.94e-05	0.00177	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.94e-05	0.00177	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.94e-05	0.00177	CbGpPWpGaD
Acebutolol—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.91e-05	0.00174	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.9e-05	0.00174	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	1.9e-05	0.00173	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	1.9e-05	0.00173	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	1.88e-05	0.00172	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	1.81e-05	0.00165	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.8e-05	0.00165	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.79e-05	0.00164	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.79e-05	0.00163	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	1.77e-05	0.00161	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	1.71e-05	0.00156	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	1.69e-05	0.00154	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.64e-05	0.0015	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.62e-05	0.00148	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	1.61e-05	0.00147	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	1.56e-05	0.00142	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	1.53e-05	0.00139	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.49e-05	0.00136	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.46e-05	0.00133	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.44e-05	0.00131	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.42e-05	0.00129	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.29e-05	0.00118	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.26e-05	0.00115	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.21e-05	0.0011	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.18e-05	0.00108	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.16e-05	0.00106	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.15e-05	0.00105	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.15e-05	0.00105	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.13e-05	0.00103	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.12e-05	0.00102	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.12e-05	0.00102	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.1e-05	0.001	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.08e-05	0.000981	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.07e-05	0.000973	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.05e-05	0.000958	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.04e-05	0.000951	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.03e-05	0.000937	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.01e-05	0.000921	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	9.87e-06	0.000901	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.75e-06	0.00089	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	9.4e-06	0.000858	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.82e-06	0.000804	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.62e-06	0.000787	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.36e-06	0.000763	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	7.51e-06	0.000685	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	7.31e-06	0.000667	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.29e-06	0.000665	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.19e-06	0.000656	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	7.13e-06	0.000651	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.03e-06	0.000641	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	6.58e-06	0.0006	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	6.49e-06	0.000592	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	6.35e-06	0.00058	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	6.2e-06	0.000566	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	6.07e-06	0.000554	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.72e-06	0.000521	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	5e-06	0.000456	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.89e-06	0.000446	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.4e-06	0.000401	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.31e-06	0.000393	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.28e-06	0.000391	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	4.21e-06	0.000384	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	4.15e-06	0.000378	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	4.04e-06	0.000368	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.86e-06	0.000352	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	3.63e-06	0.000332	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.95e-06	0.000269	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	2.89e-06	0.000264	CbGpPWpGaD
